MHRA reviewing chloramphenicol eye drops safety as service is scrapped

The MHRA is “urgently” reviewing the evidence around the safety of chloramphenicol eye drops in children under two years, after an EMA update prompted cessation of some services.

exclusive
eye%20drops%20child.jpg
EMA: Products resulting in exposure to 1mg-plus daily of boron, should not be used in under twos

Latest from News

More from Clinical